Myeloproliferative Neoplasms
📧 Sign up to get email alerts when something new happens for Myeloproliferative Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Children, Adolescents and Young Adults with Myeloproliferative Neoplasia: Study of Clinico-biological Characteristics and Complications (VYP)
Clinical trial update for a study of clinico-biological characteristics and complications in children, adolescents and young adults with mye…
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: Aquagenic Pruritus in Myeloproliferative Neoplasms
A completed clinical trial investigating aquagenic pruritus in patients with myeloproliferative neoplasms.
-
CLINICAL_TRIALS research · 2024-10-18Clinical Trial Update: Prevalence and Risk Factors of Pulmonary Hypertension in Patients with Myeloproliferative Neoplasms in Assiut University Hospital.
An observational study planned to determine prevalence and risk factors of pulmonary hypertension in patients with myeloproliferative neopla…
-
CLINICAL_TRIALS research · 2024-08-14Clinical Trial Update: Evaluation of the Prognostic Impact of Decreased Serum beta2 Microglobulin in the First Year of Follow-up of Myeloproliferative Neoplasia (PRODIGE)
Clinical trial evaluating the prognostic impact of decreased serum beta2 microglobulin in the first year of follow-up for myeloproliferative…
-
CLINICAL_TRIALS research · 2024-08-01Clinical Trial Update: Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen [Phase 2]
Phase 2 clinical trial evaluating sorafenib as relapse prophylaxis after hematopoietic cell transplantation using the PTBCy regimen; the stu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: Characterization of Myeloproliferative Neoplasia With a Mutated IDH, SRSF2 or SF3B1 Allele (CARPEDIEM)
This clinical trial update describes the CARPEDIEM study characterizing myeloproliferative neoplasms with mutated IDH, SRSF2, or SF3B1. The …
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: Diagnostic Characterization and Evolution of "Triple Negative" Thrombocytosis (CASTETTE)
This clinical trial update describes diagnostic characterization and evolution of a 'Triple Negative' thrombocytosis phenotype within myelop…
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: Observatory of Patients With MyeloProliferative Neoplasm Treated With Anti-inflammatory Immunotherapy
Status update for an ongoing trial (Observatory of Patients With Myeloproliferative Neoplasm Treated With Anti-inflammatory Immunotherapy) e…
-
CLINICAL_TRIALS research · 2018-03-29Clinical Trial Update: Clinical and Therapeutic Impact of Molecular Markers in Myeloproliferative Disorders
This clinical trial update discusses how molecular markers influence clinical management and therapy in myeloproliferative neoplasms.
-
CLINICAL_TRIALS research · 2017-07-26Clinical Trial Update: Hydroxyurea Versus Aspirin and Hydroxyurea in Essential Thrombocythemia [Phase 3]
This clinical trial update describes a Phase 3 study comparing hydroxyurea alone versus hydroxyurea with aspirin in essential thrombocythemi…
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders
A completed NIH-backed clinical trial examining molecular changes and biomarkers in chronic myeloproliferative disorders including polycythe…
-
CLINICAL_TRIALS research · 2017-06-06Clinical Trial Update: Cardiac Changes in Myeloproliferative Neoplasms [NA]
A clinical trial update examining cardiac changes in patients with myeloproliferative neoplasms; no detailed results or status are provided.
-
CLINICAL_TRIALS research · 2015-08-13Clinical Trial Update: Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor
Analysis of EBMT registry data evaluates off-label use of plerixafor in hematopoietic cell transplantation, summarizing indications and obse…
-
CLINICAL_TRIALS research · 2014-01-06Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia [NA]
This entry discusses donor stem cell transplantation as a treatment option for patients with hematologic cancers, metastatic kidney cancer, …
-
CLINICAL_TRIALS research · 2012-11-06Clinical Trial Update: Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant
The trial update describes collecting and storing tissue and DNA samples from patients undergoing donor stem cell transplantation, across mu…